|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.6 TWD | -0.21% |
|
-0.82% | -13.75% |
| Mar. 14 | Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 07 | Panion & Bf Biotech Inc. Approves Cash Dividend for 2023 | CI |
Panion & Bf Biotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 408.53 million compared to TWD 454.57 million a year ago. Net income was TWD 22.69 million compared to TWD 39.55 million a year ago.
Basic earnings per share from continuing operations was TWD 0.26 compared to TWD 0.46 a year ago. Diluted earnings per share from continuing operations was TWD 0.26 compared to TWD 0.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.75% | 257M | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
PANION & BF BIOTECH INC. 